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ABSTRACT 
Background: Non-alcoholic fatty liver disease (NAFLD) has become more common as the 
cause of cirrhosis and liver cancer. The liver disease is highly prevalent in people with type-2 
diabetes. Indonesia is not spared from the global epidemic of type-2 diabetes. The ultrasound 
examination is clinically easy-to-use, economical and non-invasive as a tool to detect NAFLD, 
compared to the gold standard, liver biopsy. To date, there has been no study in Indonesia to 
link risk factors and ultrasound-based severity grading of NAFLD. Aim: To understand the 
association between risk factors and ultrasound-based grades of NAFLD in patients with type-
2 diabetes. Method: The present study was an observational study with a cross-sectional design 
(May-October 2018) that involved 82 type-2 diabetes outpatients of the internal medicine clinic 
in the Gotong Royong Hospital (Surabaya, Indonesia). The risk factors assessed were gender, 
age, diabetes duration, obesity (anthropometric measurement: body mass index/ BMI, waist 
circumference and waist-to-hip ratio), glycemic control (hemoglobin A1c/ HbA1c level) and 
dyslipidemia (lipid profile: total cholesterol, low-density lipoprotein/ LDL, high-density 
lipoprotein/ HDL and triglyceride). The ultrasound-based grades of NAFLD consisted of grade 
0 (no NAFLD), grade 1 (increased liver echogenicity with normal images of intrahepatic vessel 
lines and diaphragm), grade 2 (blurred image of intrahepatic vessel lines) and grade 3 (blurred 
images of intrahepatic vessel lines and diaphragm). Statistical p-value was significant at ≤ 
0.05. Results: Seventy-eight subjects (95,1%) had NAFLD. The ultrasound-based NAFLD 
grades were significantly different across age groups (Kruskal-Wallis) but the Spearman’s rank 
correlation test result was not significant. Body mass index and total cholesterol were positively 
correlated (r = 0.390 and 0.237, respectively) with the NAFLD grades. Conclusion: Higher 
BMI and total cholesterol are associated with increased ultrasound-based NAFLD grades. 
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ABSTRAK 
Latar belakang: Penyakit perlemakan hati non-alkoholik menjadi lebih sering sebagai 
penyebab sirosis dan kanker hati. Penyakit hati ini memiliki prevalensi tinggi pada orang yang 
menderita diabetes tipe 2. Indonesia juga memiliki prevalensi penyakit diabetes tipe 2 yang 
tinggi seperti di dunia. Pemeriksaan ultrasonografi mudah secara klinis, murah dan tidak invasif 
untuk mendeteksi penyakit perlemakan hati non-alkoholik, dibandingkan biopsi hati sebagai 
standar emas. Sampai saat ini, belum ada studi di Indonesia yang menghubungkan faktor risiko 
dan derajat keparahan penyakit perlemakan hati non-alkoholik berdasarkan ultrasonografi. 
Tujuan: Untuk memahami hubungan antara faktor risiko dan derajat penyakit perlemakan hati 
non-alkoholik berdasarkan ultrasonografi pada pasien diabetes tipe 2. Metode: Studi ini adalah 
suatu studi observasional dengan desain potong lintang (Mei-Oktober 2018) yang melibatkan 
82 pasien diabetes tipe 2 di poli penyakit dalam, Rumah Sakit Gotong Royong (Surabaya, 
Indonesia). Faktor risiko yang dinilai adalah jenis kelamin, usia, lama menderita diabetes, 
obesitas (indeks massa tubuh, lingkar pinggang dan rasio lingkar pinggang-pinggul), kontrol 
glikemik (kadar HbA1c) dan dilipidemia (profil lipid: kolesterol total, LDL, HDL dan 
trigliserida). Derajat penyakit perlemakan hati non-alkoholik berdasarkan ultrasonografi terdiri 
dari derajat 0 (tidak ada penyakit perlemakan hati non-alkoholik), derajat 1 (peningkatan 
ekogenisitas hati dengan gambaran normal batas pembuluh darah intrahepatik dan diafragma), 
derajat 2 (pengaburan gambaran batas pembuluh darah intrahepatik) dan derajat 3 (pengaburan 
gambaran pembuluh darah intrahepatik dan diafragma). Nilai statistik p signifikan pada ≤ 0.05. 
Hasil: Tujuh puluh delapan (95,1%) subyek memiliki penyakit perlemakan hati non-alkoholik. 
Derajat penyakit perlemakan hati non-alkoholik berdasarkan ultrasonografi berbeda secara 
signifikan antar kelompok usia (Kruskal-Wallis) tetapi hasil tes korelasi Spearman tidak 
signifikan. Indeks massa tubuh (r = 0.390) dan kolesterol total (r = 0.237) berkorelasi secara 
positif dengan derajat NAFLD berdasarkan ultrasonografi. Simpulan: BMI dan kolesterol total 
yang lebih tinggi berhubungan dengan peningkatan derajat penyakit perlemakan hati non-
alkoholik berdasarkan ultrasonografi. 
Kata kunci: diabetes tipe 2, penyakit perlemakan hati non-alkoholik, faktor risiko, 
ultrasonografi 
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INTRODUCTION 
Non-alcoholic fatty liver disease is 
presently the world’s most common chronic 
liver disease. Based on results from a recent 
meta-analysis study, the disease worldwide 
prevalence is 25% (1). Owing to the change 
from an agrarian to industrial society that 
promotes an unhealthy diet and lifestyle, the 
prevalence of the disease in Asia has 
stacked up against the global one (around 
25%) (2). Although studies about NAFLD 
conducted in Indonesian communities are 
still few, a systematic review which 
gathered data from hospital-based research 
has mentioned that the prevalence of the 
disease in the country is 30% (3). 
Non-alcoholic fatty liver disease is a 
chronic liver disease which histological 
hallmarks are similar to the alcohol-induced 
liver disease but the patients have no history 
of excessive alcohol intake. It encompasses 
a spectrum of liver disease that ranges from 
simple steatosis to non-alcoholic 
steatohepatitis (NASH). The latter is likely 
to develop into liver cirrhosis and 
subsequently liver cancer. The multiple-hit 
pathogenesis is hitherto widely accepted as 
how NAFLD is initiated and progresses to 
become NASH, cirrhosis and liver cancer. 
In the pathogenesis theory, multiple factors 
are attributed to disease progression. Insulin 
resistance is followed by hepatic fat 
accumulation that causes inflammation of 
liver tissue. Gut microbiota imbalance and 
genetic predisposition are also factored in 
(4–6). A 2013 population-based study in the 
US revealed that NASH-related liver cancer 
was the second-highest cause of liver 
transplantation (7). Non-alcoholic fatty 
liver disease is also an independent risk 
factor for patients to develop cardiovascular 
diseases (8). 
Diagnosis of NAFLD has been made in 
70-75% of patients with diabetes mellitus. 
This is not surprising as insulin resistance is 
the key factor in the NAFLD pathogenesis 
(9,10). A 10-year cohort study that involved 
more than 500.000 people in China has 
shown that subjects with diabetes have 
higher risks to develop NAFLD (hazard 
ratio 1,07), cirrhosis (1,07) and liver cancer 
(1,04) than those without diabetes (11). 
About 9% of adults in the world suffered 
from diabetes mellitus in 2015 according to 
the data from The International Diabetes 
Federation and Asia as the most populous 
continent contributed the most to the 
number. It is noteworthy that Indonesia is 
the third most populous country in Asia. 
Type-2 diabetes which is lifestyle-related 
holds the majority (90%) (12).  
Age, gender and other features of 
metabolic syndrome (obesity, diabetes, and 
dyslipidemia) are risk factors of NAFLD 
that have been studied in populations (13). 
A research paper published in 2017 showed 
that the prevalence of NAFLD among 
patients with type 2 diabetes that visited 
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Cipto Mangunkusumo Hospital in Jakarta 
was 45.2% and 25.0% of these patients had 
liver fibrosis based on the fibroscan 
examination. In the study, the only risk 
factor associated with the incidence of 
NAFLD (diagnosis based on the ultrasound 
examination) was body mass index (BMI) 
(14). 
Liver biopsy remains the gold standard 
of NAFLD diagnosis with the severity 
determined histologically. However, the 
invasive nature of liver biopsy makes it the 
last resort of diagnostic means which is 
used in such cases that other etiologies of 
liver disease should be excluded in patients 
with NAFLD (4,8). Despite all the 
limitations, ultrasound is clinically easy-to-
use and low-cost as a diagnostic tool to 
detect NAFLD which usually shows no 
symptoms in the patients. Some parameters 
of ultrasonographic findings have been used 
to grade the severity of NAFLD to match 
the histological grading counterpart 
(15,16). 
Several points have become the reason 
to conduct this current research. To the best 
of our knowledge, no paper studies 
regarding the association between risk 
factors and ultrasound-based grades of 
NAFLD in Indonesia have been published. 
The management of modifiable risk factors 
such as obesity, glycemic control and 
dyslipidemia is imperative in the treatment 
of patients with NAFLD (8). We would like 
to assess if ultrasound-based grading of 
NAFLD severity is relevant to the existence 
of risk factors in type-2 diabetes patients. 
Therefore, the aim of this study is to 
understand the association between risk 
factors and ultrasound-based grades of 
NAFLD in patients with type-2 diabetes. 
SUBJECTS AND METHODS 
The observational study had a cross-
sectional design and was conducted for 6 
months (May-October 2018). Research 
subjects who were enrolled in this study 
were outpatients (age 30-80 years) of the 
internal medicine clinic in Gotong Royong 
Hospital (Surabaya, Indonesia). Ninety-
seven patients participated in the study but 
only 82 matched the criteria. The inclusion 
criteria were the agreement to participate 
voluntarily (patients filled and signed the 
informed consent) and the diagnosis of 
type-2 diabetes had been made at least 3 
months before the study was conducted. 
Patients would be excluded from the study 
if they had hepatitis B/ hepatitis C infection, 
non-NAFLD chronic liver diseases and 
anemia (hemoglobin level was lower than 
12 g/dl for males and 11 g/dl for females, 
which would lower the Hemoglobin A1c 
level). Other exclusion criteria were regular 
alcohol consumption (weekly intake more 
than 140 g for males and 70 g for females) 
and long-term treatment with hepatotoxic 
agents (e.g. isoniazid for tuberculosis 
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patients). The study protocol had gained 
approval from The Ethics Committee of 
Widya Mandala Catholic University 
Surabaya Faculty of Medicine. 
Patients filled a data form and signed 
the informed consent. Information on age, 
gender and duration of diabetes was taken 
from the data form. Ages of patients were 
categorised into 5 groups (30-39 years, 40-
49 years, 50-59 years, 60-69 years and 70-
80 years). Patients were divided into male 
and female groups based on the gender 
option in the form. Furthermore, there were  
two duration of diabetes categories, patients 
who had diabetes for < 5 years and  5 years 
(14). 
Anthropometric measurements (height 
and weight for BMI, waist circumference, 
and hip circumference) were taken 
afterwards. The BMI formula is weight in 
kilograms/ height in meters2. Patients were 
divided into two groups based on the BMI, 
ideal BMI (< 25) and overweight ( 25). For 
the waist circumference, patients were 
considered to have an ideal waist 
circumference if the circumference < 90 
centimeters (cm) for males and < 85 cm for 
females. Patients were considered to have a 
high waist circumference if the 
circumference  90 cm for males and  85 
cm for females. Another component of the 
anthropometry used for determining obesity 
was the waist-to-hip ratio which formula is 
waist circumference divided by hip 
circumference. The ideal waist-to-hip ratio 
is < 0.9 for males and < 0.85 for females. 
The high ratio is  0.9 for males and  0.85 
for females (17). 
Venous blood was taken from the 
patients to check the HbA1c (device: 
Epithod 616) and lipid profile (device: 
Cobas C111; total cholesterol, LDL, HDL 
and triglyceride) levels after fasting for 8 
hours (overnight). Patients were divided 
into two groups based on the HbA1c level, 
< 7% (good glycemic control) and  7% 
(poor glycemic control) (18). The LDL 
level is considered normal if the level < 100 
milligram (mg)/ deciliter (dl) and high if the 
level  100 mg/ dl. The HDL level is 
considered normal if the level  50 mg/ dl 
for males and  40 mg/ dl for females; and 
low if the level < 50 mg/ dl for males and < 
40 mg/ dl for females. The normal 
triglyceride level is < 150 mg/ dl and the 
high level is  150 mg/ dl (19). 
An abdominal ultrasound (device: GE, 
logic S7 expert) examination was 
performed by a competent radiologist. The 
ultrasound-based grades of NAFLD were as 
follows: (1) grade 0: normal which means 
there is no increase of the liver 
echogenicity, (2) grade 1: mild which 
means an increase of the liver echogenicity 
with normal diaphragm image and 
intrahepatic blood vessel lines, (3) grade 2: 
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moderate which means an increase of liver 
echogenicity with blurred intrahepatic 
blood vessel lines but the diaphragm image 
is still normal; and (4) grade 3: severe which 
means an increase of liver echogenicity 
with blurred diaphragm image and 
intrahepatic blood vessel lines (20). 
Data were analysed statistically using 
SPSS (Statistical Package for Social 
Sciences) version 25. The independent 
variables were age, gender, duration of 
diabetes, BMI, waist circumference, waist-
to-hip ratio, HbA1c, cholesterol, LDL, 
HDL, and triglyceride. The dependent 
variable was the ultrasound-based NAFLD 
grade. The comparative test used for the 
independent variable that consisted of two 
groups was the Mann-Whitney test and the 
Kruskal-Wallis test was for the independent 
variable with more than two groups. If the 
comparative test result was statistically 
significant, the Spearman’s correlation test 
would be conducted. The p-value was 
significant at p ≤ 0.05. 
RESULTS 
Characteristics of the study subjects 
were presented in the table 1 below. The 
characteristics were the dependent (gender, 
age, duration of diabetes, BMI, waist 
circumference, waist-to-hip ratio, and 
laboratory test results of HbA1c, 
cholesterol, LDL, HDL and triglyceride) 
and independent (ultrasound-based NAFLD 
grade) variable parameters shown in 
number, percentage and mean. In this 
current study, 78 subjects (95,1%) had 
NAFLD. Twenty-seven subjects (32,9%) 
had NAFLD grade 1 based on the 
ultrasound examination. Grade 2 and grade 
3 of NAFLD were found in 40 (48,8%) and 
11 (13,4%) subjects, respectively. 
Table 1. The characteristics of study 
subjects 
 
Non-modifiable risk factors (table 2) in 
the current research were gender, age, and 
duration of diabetes. There was no 
significant difference in ultrasound-based 
NAFLD grades between two gender groups 
in the study (p = 0.954). The significant 
difference was found across age groups (p = 
0.028), but the correlation test result was 
not significant (p = 0.691). The comparative 
test result showed no difference between the 
two groups of diabetes duration (p = 0.525). 
Table 2. Ultrasound-based NAFLD grades 
          across non-modifiable risk 
factor groups 
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*p-value ≤ 0.05 
The anthropometric parameters (table 
3) used to study the obesity risk factors were 
BMI, waist circumference and waist-to-hip 
ratio. The significant difference of 
comparative test was found between two 
BMI groups (p = 0.000) and the correlation 
test result was also significant (p = 0.000, r 
= 0.390). The p-value of comparative test 
between two waist circumference groups 
was 0.063 (no significant difference). There 
was no significant difference either between 
two waist-to-hip ratio groups (p = 0.371). 
Table 3. Ultrasound-based NAFLD grades 
across anthropometric parameters (obesity 
risk factors) 
 
*p-value ≤ 0.05 
Laboratory test parameters (table 4) 
were checked in the patients to analyse 
diabetes (glycemic control) and 
dyslipidemia risk factors. The significant 
difference was not found between two 
glycemic control groups (p = 0.437). For the 
dyslipidemia risk factors, the significant 
difference was not found between two 
groups of LDL (p = 0.966), HDL (p = 
0.575) and triglyceride (p = 0.060) levels. 
The ultrasound-based NAFLD grades were 
significantly different across two total 
cholesterol (normal and high) groups (p = 
0.033). The total cholesterol was positively 
correlated with the NAFLD grades (p = 
0.033, r = 0.237). 
Table 4. Ultrasound-based NAFLD grades 
across laboratory parameter groups 
 
*p-value ≤ 0.05 
DISCUSSION 
In the present study 95,1% of the type-
2 diabetes patients had NAFLD. Other 
hospital-based studies have shown the 
similar high prevalence of NAFLD in type-
2 diabetes patients. Based on a Chinese 
systematic review of 24 studies 54.31-
64.92% of type-2 diabetes patients have 
been diagnosed with NAFLD (21). Liver 
biopsy-proven NAFLD diagnosis has even 
been made in 87% of the type-2 patients in 
the Indian hospital (22). Data from the study 
in the hospital in Jakarta, Indonesia has 
given information that 45.2% of type-2 
diabetes patients had NAFLD (14). This 
means that the present study prevalence has 
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surpassed the one from the previous study 
in Indonesia by a high percentage. 
The current study showed that there 
was no association between gender and 
ultrasound-based NAFLD grade. This 
contradicts the theory which explains that 
free fatty acid (FFA) degradation rate is 
lower in men than women. As a result, more 
FFA accumulates in the liver of men (23). 
Previous studies have supported the theory. 
More men have NAFLD than women in a 
meta-analysis study based on 
epidemiologic research (13). Interesting 
results of gender as the risk factor come 
from a systematic review about NAFLD in 
Asia. The study has shown that before age 
50, the number of men having NAFLD is 
twice as high as the women’s number but 
when they are older, more women will have 
NAFLD (24). 
There was a significant difference in 
the NAFLD grades based on the ultrasound 
examination across age groups but no 
significant correlation was found in the 
study. A molecular biology theory supports 
the relationship between ageing and 
NAFLD. An experiment in mice which was 
comparable to ageing humans has shown 
that the lack of nicotinamide adenine 
dinucleotide (NAD+) is associated with 
NAFLD. This is because NAD+ is an 
important nucleotide as a co-factor in the 
mitochondrial activity in the liver. Thus, the 
deficiency of this element results in the 
accumulation of liver FFA. The genetically-
engineered mouse model and ageing human 
with NAFLD in the experimental study had 
the deficiency (25). Moreover, ageing is an 
independent risk factor of NAFLD-related 
liver fibrosis (26). 
Obesity is a major risk factor for both 
type 2 diabetes and NAFLD. Urbanisation 
in Asia which has changed the society from 
the agricultural one to the industrial one is 
increasing the obesity prevalence because 
of the rife unhealthy lifestyle. The high BMI 
(25) as an anthropometric measurement 
for obesity diagnosis in relation with 
NAFLD may be misleading as some Asian 
people (8-19%) with BMI <25 known as 
having ‘lean’ NAFLD (2,27). In the present 
study the higher BMI is associated with the 
increase of ultrasound-based NAFLD 
grades (the p-value of Spearman’s rank test 
was significant, 0.000 and r = 0.390). 
The aforementioned ‘lean’ 
characteristic of NAFLD in Asian 
population suggests that other 
anthropometric measurements such as waist 
circumference and waist-to-hip ratio to 
detect abdominal obesity as a more accurate 
indicator of NAFLD (2,12). However, none 
of the two anthropometric measurement 
sets of groups (ideal and high) were 
associated with ultrasound-based grades of 
NAFLD. As an explanation to these results, 
the cut-off points of the two measurements 
as the indicator to foresee that someone has 
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the potential to develop NAFLD may differ 
from one population to another (17). 
Given the notion that NAFLD is the 
hepatic feature of metabolic syndrome, this 
explains why type 2 diabetes is strongly 
associated with the metabolic liver disease. 
Moreover, insulin resistance as the cause of 
type 2 diabetes is one of the major factors in 
the pathogenesis of NAFLD (28). Another 
reason why diabetes is associated with some 
liver diseases is that the liver plays an 
important role to regulate glucose 
metabolism. In a case-control study 
conducted in an American hospital, patients 
with higher durations of diabetes had higher 
risks of developing hepatocellular 
carcinoma (29). A hospital-based study in 
Nigeria has shown that there was no 
significant difference of diabetes duration 
in different ultrasound-based NAFLD 
grades of type-2 diabetes patients (20). No 
significant difference has been found in the 
presence of NAFLD between patients who 
had type-2 diabetes  5 years and the 
counterpart in a study in Jakarta (14). The 
NAFLD grades based on ultrasonography 
were not different significantly in the two 
diabetes duration groups in our study. 
Glycemic control is imperative in 
efforts to prevent complications in type-2 
diabetes patients. The A1c type of 
hemoglobin can be used to evaluate if 
someone has a long exposure of 
hyperglycemia (18). However, there was no 
significant difference in ultrasound-based 
NAFLD grades between patients with good 
and poor glycemic control. There has not 
been a significant difference either in 
glycemic control between different NAFLD 
grades of the Nigerian type-2 diabetes 
patients (20). The glycemic control index 
which is a result of glycated albumin 
divided by HbA1c may be a better 
biomarker to predict the progression of 
NAFLD based on the ultrasound 
examination as the study in Korea has 
shown (30). 
The only component of the lipid profile 
associated with ultrasound-based NAFLD 
grades in this study was total cholesterol. 
Total cholesterol in the two groups (high 
and normal total cholesterol) was positively 
correlated with the grades. Regardless of 
the ethnicity background and locations, 
dyslipidemia is a major risk factor of 
NAFLD. Dyslipidemia prevalence along 
with obesity is increasing in Asia and 
strongly associated with the prevalence 
increase of NAFLD (31,32). A study proved 
that there is a significant link between 
dyslipidemia (the increase of total 
cholesterol, LDL, triglyceride, and the 
decrease of HDL) and the increase grades of 
NAFLD based on the ultrasound 
examination (19). 
Several limitations might have 
occurred in this study. The sample number 
might not be enough to represent the total 
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number of type-2 diabetes patients who visit 
the hospital. The risk factor categories that 
had a big discrepancy of the patient number 
in the grouping appeared to have an 
insignificant statistical result. Another 
limitation might come from the diagnostic 
tool. The ultrasound device may not detect 
hepatic steatosis when it is lower than 20%. 
Its grading system can hardly be correlated 
with the histological severity categories. 
Fibrosis in NASH cannot be detected. The 
subcutaneous fat might also cause false 
echogenicity (15,16). As a solution, the 
scoring system that combines ultrasound-
based grades with metabolic features might 
help (33). 
CONCLUSION 
The risk factors associated with 
NAFLD grades based on ultrasonography 
are age, BMI and total cholesterol. The 
higher BMI and total cholesterol are 
correlated with the increase of the NAFLD 
grades. These results suggest that the 
importance of lifestyle modification 
(healthy diet and exercise) to prevent 
NAFLD progression should be promoted 
among type-2 diabetes patients. 
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